GlassScriptPhysician profile
Kimberly Michelle Locklear
NPI 1518692425
$564.82
in general payments reported to CMS, 2019-2025
11 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $219 · 2024: $164 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $191.77 | 2023-2024 | Jornay Pm |
| Aytu Biopharma, INC. | $120.52 | 2023-2025 | Karbinal |
| Collegium Pharmaceutical, INC. | $54.25 | 2025 | Jornay Pm |
| Pfizer INC. | $38.84 | 2023-2024 | |
| Stryker Corporation | $35.98 | 2025 | Flowtriever |
| Neos Therapeutics, LP | $28.85 | 2023 | Cotempla Xr-Odt |
| Sanofi-Aventis U.S. LLC | $27.24 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $19.26 | 2023 | Farxiga |
| Corium, LLC | $17.47 | 2024 | Azstarys |
| Novo Nordisk INC | $16.69 | 2025 | |
| Sanofi Pasteur INC. | $13.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Locklear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.